Imperial College London Featured PhD Programmes
Gdansk University of Technology Featured PhD Programmes
University of Reading Featured PhD Programmes

cancer PhD Projects, Programmes & Scholarships

We have 436 cancer PhD Projects, Programmes & Scholarships

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


We have 436 cancer PhD Projects, Programmes & Scholarships

PhD saved successfully

Prostate cancer signalling to the bone micro-environment - from molecular characterization to potential novel therapies.

About the Project. Prostate cancer is responsible for over 52,000 cancer diagnoses within the UK per annum, and is the most common cancer in males, accounting for 27% of all new cancer cases diagnosed within men in 2016-2017. Read more

4-year PhD Studentship: Targeting cancer stem cells: Selective culture method and drug search

Cancer stem cells are a small population of cells in tumours maintaining the tumorigenic capacity (1). They are featured as quiescent (i.e., dormant), in contrast to the majority of cancer cells that actively proliferate under the aberrant regulation. Read more

Cancer biology: identification of new treatment options for EML4-ALK driven lung cancer through understanding mechanisms of cell division and migration.

Lung cancer is the largest cause of cancer-related deaths in the UK and worldwide. While little progress has been made in long-term survival rates, we now have a good understanding of the genetic drivers raising the prospect of earlier diagnosis and more effective treatments. Read more

Institute of Cancer Sciences

 The Institute of Cancer Sciences is part of a national centre of excellence in the fight against cancer. We carry out a programme of world-class science directed at understanding the molecular changes that cause cancer. Read more

Networks of support for people affected by a rare cancer: explicating the online communication needs of patients and families

47% of cancer diagnoses in Europe are classified as ‘less common or rare’ (Public Health England, 2014). A rare cancer is a reportedly lonely diagnosis due to lengthy and complex care pathways which can be a barrier to meeting other patients and families. Read more
Last chance to apply

Preclinical investigation of novel super-selective mTOR inhibitors in colorectal cancer

The development of potent and selective small molecules that mediate dose-dependent inhibition of a protein in its natural environment is essential to elucidate the role of such nominated target in normal and pathological settings [1]. Read more
Last chance to apply

A multimodal deep learning model to predict individual cancer patient survival probabilities

Can a deep learning framework that accommodates complex cancer ‘omics data, such as gene-expression data, with clinical phenotypic data enhance our ability to predict cancer patient survival?. Read more

Matrix cross-linking – linking diabetes to increased bowel cancer risk

Bowel cancer is the 2nd most common cause of cancer-related deaths worldwide (CRUK statistics), mainly because many patients are diagnosed in later stages of disease where response to treatment is poor - only 10% of patients with advanced disease survive for 5 years. Read more

Filtering Results